&ot&uot Kate Stern REFERENCE: O-144 KATE STERN, Royal Women’s Hospital, Melbourne A potential new way of preserving ovarian function during chemotherapy for cancer could be treatment w
&ot&uot
Kate Stern
REFERENCE: O-144KATE STERN, Royal Women’s Hospital, MelbourneA potential new way of preserving ovarian function during chemotherapy for cancer could be treatment with an antagonist of gonadotropin-releasing hormone: GnRH. A pilot study from Melbourne looked at 18 young women with cancer or auto immune disease due to receive cyclophosphamide therapy. Sarah Maxwell spoke withKate Sternand heard more about the study.